An analysis of antibody responses to more than 90,000 viral protein fragments shows that age, biological sex, and genetic ...

Wondering why the same virus hits you worse A recent study reveals the influence of age and sex on our immune response Read ahead to find out ...

A virus that typically infects black-eyed peas is showing great promise as a low-cost, potent cancer immunotherapy—and researchers are uncovering why. In a study published in Cell Biomaterials, a team ...

Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, offering a unique potential to selectively target malignant cells while sparing normal tissues.

A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and ...

Epstein–Barr virus infects most adults. Understanding its role in Multiple Sclerosis could transform prevention and treatment ...

Secondary infections caused by bacteria or viruses during hospital care remain a long-standing global challenge, despite ...

In a recent study published in the journal PLOS Pathogens, researchers investigated humoral and cell-mediated immune responses to Epstein-Barr virus (EBV) in multiple sclerosis (MS) patients, ...

A type of immune cell targeting the Epstein-Barr virus may play a key role in driving multiple sclerosis (MS), a study found.

Age strongly influences antibody production against viruses, researchers find. A Nature Immunology study shows age, sex, and ...

Human cytomegalovirus triggers an immune response before it actually enters the cell, according to a report from researchers at the University of Wisconsin-Madison and the University of Massachusetts ...